Event Info
Date: Saturday, November 21, 2026
Location: La Cantera Resort & Spa, San Antonio, Texas
Event Website: San Antonio Advanced Lung Symposium
About the Event
Cizzle Bio is proud to be a Bronze-Level Sponsor of the 2026 San Antonio Advanced Lung Symposium, taking place November 21 at La Cantera in San Antonio.
The symposium brings together healthcare professionals for case-based, interactive education on the management of advanced lung conditions. Presentations will draw on current guidelines and practice-based experience from expert centers, highlighting developments relevant to clinical practice.
The program is designed for physicians, nurse practitioners, physician assistants, fellows, residents and nurses involved in caring for patients with advanced lung conditions. Its multidisciplinary audience includes professionals in pulmonology, radiology, oncology, primary care and other specialties.
Symposium Focus
The symposium’s learning objectives include:
Reviewing surgical management and nonsurgical options for early-stage lung cancer.
Exploring approaches to diagnosing and managing upper airway disease and asthma.
Identifying and screening candidates for lung transplantation.
Discussing the triage of pulmonary embolism patients who may need advanced therapies.
Why Cizzle Bio Is Supporting the Symposium
As a company advancing biomarker blood tests for earlier cancer detection, Cizzle Bio values opportunities to connect with healthcare professionals working across the lung care continuum. Supporting this symposium reflects our commitment to clinical education, collaboration and informed conversations about lung cancer assessment.
Cizzle Bio’s CIZ1B Biomarker Blood Test for Lung Cancer is designed to provide additional biomarker information that may support clinical decision-making in lung cancer assessment alongside imaging and other diagnostic tools.
Founder and CEO Bill Behnke plans to attend, and Cizzle Bio will have an exhibit table at the event. We look forward to connecting with the San Antonio medical community and sharing information about innovative biomarker blood test.